Technology Pioneer 2012 - Randy Strahan (Tethys Bioscience)

TL;DR

A groundbreaking diagnostic company aims to preempt and prevent cardio-metabolic diseases, like diabetes, with personalized risk assessments.

Transcript

What about your company makes it unique? Randy Strahan: I have a history of diabetes in my family and so the first thing when I came here was to get the test myself to see what my risk was. I'm a high risk for diabetes. Getting this score does cause you to go "wow, I would better do something about that." Everybody has got a relative that is a d... Read More

Key Insights

• ✳️ Tethys utilizes personalized risk assessment to preempt diseases like diabetes.
• ❓ Cardio-metabolic diseases have a significant impact globally, both clinically and economically.
• 😫 The focus on prevention through targeted interventions sets Tethys apart in the diagnostics field.
• ✳️ Identifying high-risk individuals within low-risk populations can lead to more effective prevention measures.
• 🧑‍⚕️ Tethys aims to improve global health outcomes by revolutionizing disease prevention strategies.
• 🗯️ By focusing on the right individuals, Tethys believes healthcare dollars can be used more judiciously.
• 💾 Diagnostic advancements like PreDx have the potential to save healthcare costs and reduce complications.

Questions & Answers

Q: What sets Tethys apart from other diagnostic companies?

Tethys is unique in its approach of identifying high-risk individuals within low-risk populations, allowing for targeted disease prevention measures rather than broad interventions. This personalized risk assessment sets Tethys apart in the field of diagnostics.

Q: How does Tethys contribute to improving global health outcomes?

By preempting and preventing diseases like diabetes, Tethys not only saves healthcare costs but also decreases complications and improves quality of life for individuals. This targeted approach has the potential to revolutionize healthcare worldwide.

Q: What is the key focus of Tethys in its diagnostic efforts?

Tethys focuses on cardio-metabolic diseases, recognizing their clinical and economic impact. By understanding the unmet needs in diagnostics and targeting the right individuals for prevention, Tethys aims to make a significant difference in disease prevention.

Q: How does Tethys believe its approach can save healthcare costs?

By using the PreDx tool to identify high-risk individuals accurately, Tethys can focus resources where needed most, potentially saving up to a quarter of a trillion dollars in the United States alone. This targeted approach can lead to more efficient healthcare spending.

Summary & Key Takeaways

• Tethys focuses on personalized risk assessment for diabetes prevention.

• Utilizes advanced technology to identify high-risk individuals within low-risk populations.

• Aims to revolutionize disease prevention by targeting prevention measures effectively.